United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read Chemical Industry News Galaxy Surfactants (NSE: GALAXYSURF) Q3 FY26 results signal portfolio resilience as specialty growth offsets global surfactant pressures Galaxy Surfactants Limited Q3 FY26 results reveal how specialty care growth is offsetting global surfactant pressure. Find out what this means for investors. byVenkateshFebruary 14, 2026